Author

Zachary Fogassy

Observed names: Zachary N Fogassy, Zachary N. Fogassy

Institution: aTyr Pharma (United States)

Observed institutions: aTyr Pharma (United States), University of California, Davis

ORCID: 0000-0001-8323-2111

Observed ORCID: 0000-0001-8323-2111

OpenAlex ID: A5091330155

Optimal protection against Salmonella infection requires noncirculating memory

2018 · Joseph M. Benoun, Newton G. Peres, et al. · Proceedings of the National Academy of Sciences · 53

Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer

2023 · Zhiwen Xu, Hira Lal Goel, et al. · Science Translational Medicine · 49

Dual Immunization with SseB/Flagellin Provides Enhanced Protection against Salmonella Infection Mediated by Circulating Memory Cells

2017 · Seung-Joo Lee, Joseph Benoun, et al. · The Journal of Immunology · 36

Antibiotic treatment causes a reduction in antigen-specific T cell memory and increased susceptibility to secondary infection

2017 · Joseph M Benoun, Jasmine C Labuda, et al. · The Journal of Immunology · 2

Abstract 1758: Resistance to cancer therapy via upregulation of the NRP2/VEGF-C axis can be neutralized by ATYR2810

2023 · Alison Barber, Zhiwen Xu, et al. · Cancer Research

Abstract LB085: ATYR2810, a fully humanized monoclonal antibody targeting the VEGF-NRP2 pathway sensitizes highly aggressive and chemoresistant TNBC subtypes to chemotherapy

2022 · Zhiwen Xu, Alison Barber, et al. · Cancer Research

Examining pathogen specific T cell responses during antibiotic intervention (MPF2P.743)

2015 · Joseph Benoun, Zachary Fogassy · The Journal of Immunology

Works count: 7

Citation count: 140

H-index: 3

I10-index: 3